NTLA
NASDAQ · Biotechnology
Intellia Therapeutics Inc
$12.14
-0.12 (-0.98%)
Analyst Consensus
Buy
24
Analysts
High
Coverage
Price Target
Analyst Price Target
+167.8% upside
Low Target
$20.88
Average Target
$32.51
High Target
$45.64
Current Price
$12.14
Current
$12.14
$12.14
Target
$32.51
$32.51
$20.88
$32.51 avg
$45.64
Scenario Analysis
Bear Case
$20.88
72.0%
Low target
Base Case
$32.51
+167.8%
Avg target
Bull Case
$45.64
+275.9%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$28.25
-57.0% from high
52-Week Low
$7.95
+52.7% from low
Target vs 52W High
$32.51
+15.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |